Ajanta Pharma Promoter Ravi Agrawal (via Ravi Agrawal Trust) has released a pledge on 2,600 equity shares.

This move, attributed to 'Excess Pledge', slightly reduces the number of previously pledged shares for this specific promoter.

This is a small positive for investor sentiment, indicating reduced encumbrance.